Impaired response to insulin associated with protein kinase C in chronic fructose-induced hypertension

Blood Pressure

Volumn 11, Issue 6, 2002, Pages 345-351

  Damiano, P ^a   Cavallero, S ^a   Mayer, M ^a   Roson M I ^a   De La Riva, I ^a   Fernandez B ^a   Puyo A M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Fructose fed rats; Hypertension; Insulin resistance; Natriuretic; Nitric oxide; Peptides; Protein kinases; Vascular contractility

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALPHOSTIN C; FRUCTOSE; GLUCOSE; INSULIN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; PHENYLEPHRINE; PHORBOL DIBUTYRATE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CARBOHYDRATE INTAKE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; HYPERTENSION; INCUBATION TIME; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; THROMBOSIS;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WEIGHT; ENZYME ACTIVATORS; ENZYME INHIBITORS; FRUCTOSE; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NAPHTHALENES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 12244265470     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370502321095302     Document Type: Article

References (34)

1. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10: 512-16.
2. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988; 37: 1597-607.
3. Togashi N, Ura N, Higashiura K, Murakami H, Shimamoto K. The contribution of skeletal muscle tumor necrosis factor-α to insulin resistance and hypertension in fructose-fed rats. J Hypertens 2000; 18: 1605-10.
4. Bernal CA, Gutman RA, Lombardo YB. The duration of feeding on a sucrose-rich diet determines variable in vitro effects of insulin and fructose on rat liver triglyceride metabolism. J Nutr Biochem 1995; 6: 422-30.
5. Chicco A, Soria A, Fainstein-Day P, Gutman RA, Lombardo YB. Multiphasic metabolic changes in the heart of rats fed a sucrose-rich diet. Horm Metab Res 1994; 26: 397-403.
6. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996; 93: 1331-3.
7. Cantin M, Genest J. The heart and the atrial natriuretic factor. Endocr Rev 1985; 6: 107-27.
8. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981; 28: 89-94.
9. Puyó AM, Vega GW, Pellegrino de Iraldi A, et al. Atrial natriuretic factor in two kidney-two clip renovascular hypertension in the rat. Medicina (B. Aires) 1998; 58: 165-70.
10. Puyó AM, Levin GM, Armando I, Donoso AS, Fernández BE, Barontini MB. Increased plasma atrial natriuretic factor in catecholamine-producing tumors. Clin Exp Hypertens 1999; 21: 1129-44.
11. Hwang IS, Huang WC, Wu JN, Shian LR, Reaven GM. Effect of fructose-induced hypertension on the reninangiotensin-aldosterone system and atrial natriuretic factor. Am J Hypertens 1989; 2: 424-7.
12. Damiano PF, Rosón MI, Armando I, et al. Potential role of glycerol leading to rat fructose hypertension. Hypertension 1999; 34 (part 2): 1007-11.
13. Trombino C, Tazi KA, Gadano A, Moreau R, Lebrec D. Protein kinase C alterations in aortic vascular smooth muscle cells from rats with cirrhosis. J Hepatol 1998; 28: 670-6.
14. Herbert V, Lan KS, Gottieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965; 25: 1375-84.
15. Moshage H, Kok B, Huizenga J, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995; 41: 892-6.
16. Sarda IR, de Bold ML, de Bold AJ. Optimization of atrial natriuretic factor immunoassay. Clin Biochem 1989; 22: 11-15.
17. Bruns RF, Miller FD, Merriman RL, et al. Inhibition of protein kinase C by Calphostin C is light-dependent. Biochem Biophys Res Commun 1991; 176: 288-93.
18. Rosón MI, Speziale E, Celentano MM, et al. Serotonin hypersensitivity in aorta of two kidney-two clip hypertensive rats: calcium contribution and prostanoids-nitric oxide interactions. Arch Physiol Biochem 2001; 109: 32-7.
19. Shimamoto Y, Shimamoto H, Kwan CY, Daniel EE. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am J Physiol 1993; 264: H1300-6.
20. Lombardo YB, Drago S, Chicco A, et al. Long-term administration of a sucrose-rich diet to normal rats: relationship between metabolic and hormonal profiles and morphological changes in the endocrine pancreas. Metabolism 1996; 45: 1527-32.
21. Fang TC, Huang WC. Role of angiotensin II in hyperinsulinemia-induced hypertension in rats. J. Hypertens 1998; 16: 1767-74.
22. Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilatation: physiology and pharmacology. Diabetologia 1998; 41: 369-79.
23. Heise T, Magnusson K, Heinemann L, Sawicki PT. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 1998: 32: 243-8.
24. Haffner SM. Metabolic predictors of hypertension. J Hypertens 1999; 17 Suppl 3: S23-8.
25. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997; 29: 691-9.
26. Osei K. Insulin resistance and systemic hypertension. Am J Cardiol 1999; 84: 33-6J.
27. 2+ influx. J Nutr 1995; 125 Suppl 6: 1732-7s.
28. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats. Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992; 89: 11059-63.
29. 2+ concentration. Am J Physiol 1998; 274 (5 Pt 1): E885-92.
30. King GL, Kunisaki M, Nishio Y, Inoguchi T, Shiba T, Xia P. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 1996; 45 Suppl 3: S105-8.
31. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994; 94: 2511-15.
32. Lee MW, Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC actions. Am J Physiol 1994; 267: C659-78.
33. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension 1996; 28: 159-68.
34. Williams B. Mechanical influences on vascular smooth muscle cell function. J Hypertens, 1998; 16: 1921-9.